PFG
ABMD

PAX Financial Group’s Abiomed Inc ABMD Stock Holding History

PAX Financial Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,167
Closed -$778K – 217
2022
Q3 		$778K Buy
3,167
+172
+6% +$46.4K 0.2% 81
2022
Q2 		$741K Sell
2,995
-145
-5% -$39.1K 0.19% 85
2022
Q1 		$1.04M Buy
3,140
+361
+13% +$111K 0.24% 61
2021
Q4 		$998K Buy
2,779
+338
+14% +$114K 0.22% 67
2021
Q3 		$795K Buy
2,441
+507
+26% +$172K 0.19% 84
2021
Q2 		$604K Buy
1,934
+683
+55% +$210K 0.15% 114
2021
Q1 		$399K Buy
+1,251
New +$400K 0.11% 121

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PAX Financial Group's ABMD Position: Q4 2022 in Review

PAX Financial Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,167 shares — an estimated $778K sold.

PAX Financial Group first reported a position in ABMD in Q1 2021 and held it in 7 quarters. The position peaked at $1.04M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • PAX Financial Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • PAX Financial Group sold 3,167 Abiomed Inc shares in Q4 2022, an estimated $778K.
  • PAX Financial Group first reported a position in Abiomed Inc in Q1 2021 and held it in 7 quarters.
  • PAX Financial Group's Abiomed Inc position peaked at $1.04M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on PAX Financial Group's 13F filing for Q4 2022, filed 10 Feb 2023.